U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from PMC

Items: 13

1.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer [ChIP-Seq]

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL24676
64 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE232086
ID:
200232086
2.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer [RNA-Seq]

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
22 Samples
Download data: CSV
Series
Accession:
GSE232085
ID:
200232085
3.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Methylation profiling by array; Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL13534 GPL18573 GPL24676
386 Samples
Download data: BW, IDAT, NARROWPEAK
Series
Accession:
GSE202776
ID:
200202776
4.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX Methylation)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platform:
GPL13534
15 Samples
Download data: IDAT, TSV
Series
Accession:
GSE202775
ID:
200202775
5.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (Cell lines Methylation)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platform:
GPL13534
34 Samples
Download data: IDAT, TSV
Series
Accession:
GSE202774
ID:
200202774
6.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX RNA-Seq)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18573
15 Samples
Download data: CSV
Series
Accession:
GSE202773
ID:
200202773
7.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX H3K27ac ChIP-Seq)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL18573
24 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE202772
ID:
200202772
8.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (Cell lines scRNA-Seq)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
23 Samples
Download data: RDATA
Series
Accession:
GSE202771
ID:
200202771
9.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (TNBC cell lines RNA-Seq)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18573
34 Samples
Download data: CSV
Series
Accession:
GSE202770
ID:
200202770
10.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PRRX1 OE RNA-Seq)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
48 Samples
Download data: CSV
Series
Accession:
GSE202769
ID:
200202769
11.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PRRX1 KD RNA-Seq)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18573
16 Samples
Download data: CSV
Series
Accession:
GSE202768
ID:
200202768
12.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PRRX1 ChIP-Seq)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL18573
31 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE202767
ID:
200202767
13.

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (H3K27ac cell lines ChIP-Seq)

(Submitter supplied) Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL18573
60 Samples
Download data: BW, NARROWPEAK
Series
Accession:
GSE202766
ID:
200202766
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=2|blobid=MCID_66c7f007c8112916c0bb83f0|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center